IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics Inc

CUSIP: 48576UAD8 | 4 institutional holders

Quarters

Q3 2025Q2 2025Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Braidwell LP48,482,000
1.0% of portfolio›$35.0M
Highbridge Capital Management LLC23,625,000
0.8% of portfolio›$17.7M
Context Capital Management, LLC8,871
0.2% of portfolio›$6.4M
StyleTurnoverLocationFiled
Braidwell LP
48,482,000$35.0M1.0%CoreHighStamford, CT2025-11-14
Highbridge Capital Management LLC
23,625,000$17.7M0.8%ValueVery HighNew York, NY2025-11-10
Context Capital Management, LLC
8,871$6.4M0.2%GrowthHighGreenwich, CT2025-11-12